Category: Include on Menu
-
ClearPoint Neuro Shares Jump as FDA Progress for UniQure Therapy Highlights Platform Value
ClearPoint Neuro (NASDAQ:CLPT) surged 50% on Wednesday after partner company UniQure announced a significant regulatory milestone for its Huntington’s disease treatment candidate, AMT-130. Investors responded positively to the update, which could accelerate development of a therapy that relies on ClearPoint’s technology platform for delivery. UniQure Receives Positive FDA Feedback UniQure (NASDAQ:QURE) disclosed that the U.S.…
-
uniQure Positioned for Gains After FDA Supports Accelerated Approval Path for AMT-130
uniQure N.V. (NASDAQ:QURE) was halted pending news on Wednesday and appeared set for a strong move higher once trading resumed after announcing positive regulatory feedback from the U.S. Food and Drug Administration regarding its Huntington’s disease treatment candidate, AMT-130. The company said the FDA has agreed that data from its ongoing Phase I/II study could…
-
Ormat Technologies Shares Slide After Bernstein Starts Coverage With Underperform Rating
Ormat Technologies (NYSE:ORA) moved lower in premarket trading on Wednesday after Bernstein SocGen Group initiated coverage of the geothermal energy company with an Underperform recommendation and a $115 price target. The shares had closed Tuesday at $133.96, leaving the analyst’s target roughly 14% below the stock’s latest closing price. Analyst Highlights Concerns Over Geothermal Exploration…
-
NeoVolta Shares Surge After Needham Launches Coverage With Buy Rating
NeoVolta Inc. (NASDAQ:NEOV) climbed 20% on Wednesday after Needham initiated research coverage on the energy storage company with a Buy recommendation and an $8.00 price target. The stock had finished Tuesday’s session at $1.71, meaning the new target suggests potential upside of more than 300% from the previous closing price. Analyst Sees Significant Opportunity in…
-
Jazz Pharmaceuticals and AbCellera Partner on Antibody Programs for Solid Tumors
Jazz Pharmaceuticals (NASDAQ:JAZZ) and AbCellera (NASDAQ:ABCL) have signed a preclinical collaboration, option and licensing agreement focused on the discovery and development of T-cell engaging multispecific antibodies for gastrointestinal cancers and other solid tumors. The partnership combines AbCellera’s antibody discovery capabilities with Jazz’s oncology development expertise as the companies seek to advance new cancer therapies. Initial…
-
Uber, Nuro and Lucid Target Houston Robotaxi Launch in 2027
Uber Technologies (NYSE:UBER), Nuro and Lucid Group (NASDAQ:LCID) have unveiled plans to introduce a robotaxi service in Houston by mid-2027, expanding their autonomous mobility partnership beyond the San Francisco Bay Area, where operations are scheduled to begin later this year. The announcement represents the second planned deployment under the companies’ joint autonomous vehicle initiative as…
-
Semiconductor Stocks Climb in Premarket Trade Following Intel Manufacturing Milestone
Chipmakers moved higher in premarket trading on Wednesday, with Intel (NASDAQ:INTC) leading the sector after announcing a significant advancement in its next-generation manufacturing technology. The gains helped reverse some of the weakness seen across semiconductor stocks during Tuesday’s session, lifting sentiment across the broader industry. Intel Leads Sector Higher Intel shares rose roughly 4% before…
-
CarMax Tops Expectations as Growth Plan Gains Momentum (KMX)
CarMax Inc. (NYSE:KMX) delivered first-quarter results ahead of market forecasts, with both earnings and revenue surpassing analyst expectations as the company’s recently introduced four-pillar strategy began to show encouraging signs of progress. Adjusted earnings per share came in at $1.31, exceeding the consensus estimate of $0.96 by $0.35. Revenue increased 6.2% year over year to…
-
Intel Shares Rise After 18A-P Manufacturing Process Reaches Key Production Milestone
Intel (NASDAQ:INTC) moved higher in premarket trading on Wednesday after revealing that its advanced 18A-P chip manufacturing technology has entered risk production, an important phase that precedes volume manufacturing. The development marks another step forward in Intel’s effort to execute on its semiconductor manufacturing strategy and attract additional customers to its growing foundry business. Shares…
-
SpaceX Adds to Historic Rally as Market Value Moves Beyond Amazon
SpaceX (NASDAQ:SPCX) continued its remarkable post-listing advance on Tuesday, overtaking Amazon.com’s (NASDAQ:AMZN) market capitalization and briefly surpassing Microsoft as it climbed the ranks of the world’s most valuable publicly traded companies. The stock finished the session up 4.83% at $201.80, giving the aerospace and technology group an implied valuation of approximately $2.66 trillion, around $8…